Omnicell OMCL
NASDAQ OMCL
$38.06 +0.72 (+1.93%)
As of: Nov 9, 2026 · 10:31 AM EST

Omnicell (OMCL) Gains (Losses) on Sale of Assets & Investments (2015)

Updated

Omnicell (OMCL) posted Gains (Losses) on Sale of Assets & Investments of $3.44 million for FY2015.

Analysis

Omnicell (OMCL) Gains (Losses) on Sale of Assets & Investments (2015) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gains on Sales (Qtr)
1 Thermo Fisher Scientific 259.72 Bn 236.23 Bn 5.13 Bn -
2 Abbott Laboratories 189.64 Bn 163.50 Bn 7.39 Bn -
3 Danaher 162.60 Bn 142.26 Bn 3.84 Bn -
4 Intuitive Surgical 159.47 Bn 139.76 Bn 2.08 Bn -
5 Medtronic 130.12 Bn 95.37 Bn 6.34 Bn -
6 Stryker 124.71 Bn 110.89 Bn 4.25 Bn -
7 Boston Scientific 63.08 Bn 58.52 Bn 3.43 Bn -
8 Edwards Lifesciences 59.73 Bn 42.93 Bn 1.35 Bn -
9 Becton Dickinson 58.27 Bn 55.42 Bn 2.32 Bn -
10 Omnicell 1.75 Bn 702.93 Mn 137.83 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2015 3.44 Mn
API Access

Omnicell Gains (Losses) on Sale of Assets & Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=OMCL&period=max&api_key=YOUR_API_KEY